November 13, 2012

Pleasanton, CA — To maximise its growing presence and accelerate growth in key emerging markets, contact lens manufacturer CooperVision, Inc. (NYSE:COO) will establish a new operating region. Effective November 1, 2012 the new operating unit will include the fast growing economies of India, Pakistan, the Middle East, Turkey, Russia and Africa.

“We want to capitalise on the strong support we see for our branded products in these markets and continue to refine our commercial approach to both vision care professionals and consumers. This organisational investment will allow us to blend the success we have had in more established markets with regional buying behaviours,” said Dennis Murphy, executive vice president of global sales & marketing for CooperVision. “Creating a dedicated regional management team will focus resources and localised strategies to increase product adoption while providing the best solutions for vision correction.”

Michael Wilkinson, the company’s current vice president of marketing for Europe, the Middle East and Africa, has been named general manager for the new region. He joined CooperVision in 2006 as general manager for the UK and Ireland, and previously held roles with Parfums Givenchy and Gillette.

About CooperVision

CooperVision, a unit of The Cooper Companies, Inc. (NYSE:COO), is one of the world's leading manufacturers of soft contact lenses. Dedicated to continually bringing a refreshing perspective to the contact lens experience for practitioners and patients, CooperVision specializes in lenses for astigmatism, presbyopia, and ocular dryness. The company routinely collaborates with eye care professionals in the research and development of relevant products. CooperVision manufactures a full array of monthly, two-week, and daily disposable contact lenses featuring advanced materials and optics. For more information, visit www.coopervision.com.

About The Cooper Companies

The Cooper Companies, Inc. (“Cooper”) is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women’s health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, CA, Cooper has over 7,500 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.